SkyView Investment Advisors’s Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock VHAQ.RT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-389,264
Closed 352
2024
Q4
$0 Buy
+389,264
New ﹤0.01% 377
2024
Q3
Sell
-389,264
Closed -$20K 359
2024
Q2
$20K Hold
389,264
﹤0.01% 289
2024
Q1
$20K Buy
+389,264
New +$25.5K ﹤0.01% 276
2023
Q4
Sell
-389,264
Closed -$23K 557
2023
Q3
$23K Hold
389,264
0.01% 315
2023
Q2
$22K Hold
389,264
0.01% 434
2023
Q1
$19K Hold
389,264
﹤0.01% 432
2022
Q4
$51K Hold
389,264
0.02% 374
2022
Q3
$47K Hold
389,264
0.01% 417
2022
Q2
$31K Hold
389,264
0.01% 465
2022
Q1
$47K Buy
389,264
+72,409
+23% +$11.6K 0.01% 469
2021
Q4
$58K Hold
316,855
0.01% 452
2021
Q3
$63K Buy
+316,855
New +$69.9K 0.02% 355

SkyView Investment Advisors's VHAQ.RT Position: Q1 2025 in Review

SkyView Investment Advisors sold out of Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock (VHAQ.RT) in Q1 2025, closing a stake of 389,264 shares.

SkyView Investment Advisors first reported a position in VHAQ.RT in Q3 2021 and held it in 12 quarters. The position peaked at $63K in Q3 2021. 0 funds tracked by Wall St. Rank hold VHAQ.RT as of Q1 2025.

  • SkyView Investment Advisors reported no remaining Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock position as of Q1 2025 after selling out during the quarter.
  • SkyView Investment Advisors sold 389,264 Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock shares in Q1 2025.
  • SkyView Investment Advisors first reported a position in Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock in Q3 2021 and held it in 12 quarters.
  • SkyView Investment Advisors's Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock position peaked at $63K in Q3 2021.
  • 0 funds tracked by Wall St. Rank held Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock as of Q1 2025.

Based on SkyView Investment Advisors's 13F filing for Q1 2025, filed 15 Aug 2025.